SIM
STML

Spark Investment Management’s Stemline Therapeutics, Inc. STML Stock Holding History

Spark Investment Management’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10,700
Closed -$67K – 879
2015
Q4 		$67K Buy
+10,700
New +$86.8K 0.01% 689
2013
Q4 		– Sell
-38,300
Closed -$1.73M – 729
2013
Q3 		$1.73M Buy
38,300
+17,700
+86% +$577K 0.4% 59
2013
Q2 		$487K Buy
+20,600
New +$328K 0.13% 200

Other funds holding STML

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Spark Investment Management's STML Position: Q1 2016 in Review

Spark Investment Management sold out of Stemline Therapeutics, Inc. (STML) in Q1 2016, closing a stake of 10,700 shares — an estimated $67K sold.

Spark Investment Management first reported a position in STML in Q2 2013 and held it in 3 quarters. The position peaked at $1.73M in Q3 2013. 63 funds tracked by Wall St. Rank hold STML as of Q1 2016.

  • Spark Investment Management reported no remaining Stemline Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
  • Spark Investment Management sold 10,700 Stemline Therapeutics, Inc. shares in Q1 2016, an estimated $67K.
  • Spark Investment Management first reported a position in Stemline Therapeutics, Inc. in Q2 2013 and held it in 3 quarters.
  • Spark Investment Management's Stemline Therapeutics, Inc. position peaked at $1.73M in Q3 2013.
  • 63 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q1 2016.

Based on Spark Investment Management's 13F filing for Q1 2016, filed 12 May 2016.